Changes in particulate neuraminidase activity during normal and staggerer mutant mouse development

Area of Science:

• Neuroscience
• Biochemistry
• Developmental Biology

Background:

• Particulate neuraminidase (sialidase) plays a role in cellular processes.
• Developmental changes in enzyme activity are crucial for tissue function.
• The Staggerer mouse is a model for studying neurological development and mutations.

Purpose of the Study:

• To investigate the developmental activity of particulate neuraminidase in wild-type and Staggerer mice.
• To determine if the Staggerer mutation affects neuraminidase activity timing in different tissues.
• To assess the specificity of observed changes by examining other glycosidases.

Main Methods:

• Enzyme activity assays were performed on tissue homogenates (cerebellum, cerebrum, liver).
• Studies were conducted during postnatal development (P3, P27) in wild-type and Staggerer mice.
• Activity of neuraminidase and other glycosidases was quantified.

Main Results:

• Peak particulate neuraminidase activity occurred at postnatal day 3 (P3) in wild-type mice across cerebellum, cerebrum, and liver.
• In Staggerer mice, peak cerebellar neuraminidase activity was delayed until P27.
• Neuraminidase activity in Staggerer cerebrum and liver, and other glycosidases in all tissues, showed no significant deviation from wild-type at P27.

Conclusions:

• The Staggerer mutation specifically delays particulate neuraminidase activity in the cerebellum.
• This delayed activity is not a general defect in lysosomal enzyme expression or activity.
• Findings suggest a specific role for neuraminidase in cerebellar development affected by the Staggerer mutation.